TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding TScan Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 54 | 66 | +12 |
| Shares | 31.9M | 34.3M | +2.38M (+7.5%) |
| Value | $186.1M | $272.3M | +$86.3M (+46.4%) |
New holders (17)
Institutions that held TScan Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Invesco Ltd. | 488,415 | $3.88M | 0.00% |
| Tocqueville Asset Management L.P. | 212,200 | $1.68M | 0.03% |
| Marathon Trading Investment Management LLC | 51,000 | $404.9K | 0.16% |
| Two Sigma Investments, LP | 37,747 | $299.7K | 0.00% |
| HRT Financial LP | 34,789 | $276.0K | 0.00% |
| Brevan Howard Capital Management LP | 34,578 | $274.5K | 0.02% |
| Point72 Asia (Singapore) Pte. Ltd. | 19,736 | $156.7K | 0.04% |
| Cannon Global Investment Management, LLC | 17,500 | $138.9K | 0.37% |
| Credit Suisse AG | 17,366 | $137.9K | 0.00% |
| Omers Administration Corp | 14,200 | $112.7K | 0.00% |
| Jefferies Financial Group Inc. | 12,200 | $96.9K | 0.00% |
| Citadel Advisors LLC | 11,432 | $90.8K | 0.00% |
| CTC Alternative Strategies, Ltd. | 11,000 | $87.3K | 0.05% |
| Jump Financial, LLC | 10,291 | $81.7K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,061 | $80.0K | 0.00% |
| Federated Hermes, Inc. | 56 | $445 | 0.00% |
| Macquarie Group Ltd | 1,618 | $13 | 0.00% |
Sold out (5)
Institutions that held TScan Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| 683 Capital Management, LLC | 43,198 | $251.8K |
| Virtu Financial LLC | 18,418 | $107.0K |
| Bank of New York Mellon Corp | 16,670 | $97.2K |
| Boothbay Fund Management, LLC | 13,293 | $77.5K |
| Tower Research Capital LLC (TRC) | 43 | $251 |